L3VLUP
ProSign in

PCRX in the 13F filings

Pacira Biosciences Inc · CUSIP 695127100

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
30 Jun 2026
the date the book describes
Filed
27 Oct 2026
latest of these filings; the earliest 3 Aug 2026
Managers listing it
24
at least, of 95 tracked, among listed positions
Comparable managers
91
filed both Q1 2026 and Q2 2026; 3 listed it in both
Shares listed
6,721,716
combined, among listed positions
Reported value
$170m
combined, at the quarter end

AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.

Among the 91 comparable managers: 14 buyers (opened or added shares) and 13 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -167,286.

Managers listing PCRX in Q2 2026

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q1 2026, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

24 of 24 holders

ActionFiling
D. E. Shaw & Co.1,950,332$49munder 0.1%Trimmed-32,39214 Aug 2026 (the filing on sec.gov)
Renaissance Technologies LLC1,733,801$44m0.06%Trimmed-91,70013 Aug 2026 (the filing on sec.gov)
Two Sigma Investments LP724,604$18munder 0.1%Added+197,75314 Aug 2026 (the filing on sec.gov)
Wellington Management Group LLP563,458$14munder 0.1%Added+85,07514 Aug 2026 (the filing on sec.gov)
Invesco Ltd249,350$6.3munder 0.1%Added+11,77014 Aug 2026 (the filing on sec.gov)
Millennium Management LLC235,163$6.0munder 0.1%Added+178,13214 Aug 2026 (the filing on sec.gov)
Fidelity (FMR LLC)217,001$5.5munder 0.1%Added+123,52013 Aug 2026 (the filing on sec.gov)
Citadel Advisors LLC162,164$4.1munder 0.1%Trimmed-635,1172 Sep 2026 (the filing on sec.gov)
AQR Capital Management LLC158,511$4.0munder 0.1%Added+4,21314 Aug 2026 (the filing on sec.gov)
PDT Partners LLC132,368$3.4m0.18%Held014 Aug 2026 (the filing on sec.gov)
Marshall Wace LLP129,348$3.3munder 0.1%Newnew13 Aug 2026 (the filing on sec.gov)
Man Group PLC125,370$3.2munder 0.1%Newnew14 Aug 2026 (the filing on sec.gov)
T. Rowe Price Associates Inc61,860$1.6munder 0.1%Added+7,88314 Aug 2026 (the filing on sec.gov)
ExodusPoint Capital Management LP60,963$1.5munder 0.1%Newnew14 Aug 2026 (the filing on sec.gov)
Caxton Associates LLP56,917$1.4munder 0.1%Added+21,60414 Aug 2026 (the filing on sec.gov)
AllianceBernstein LP50,693$1.1munder 0.1%Trimmed-2,30014 Aug 2026 (the filing on sec.gov)
MFS Investment Management31,178$791kunder 0.1%Newnew3 Aug 2026 (the filing on sec.gov)
Quantbot Technologies LP19,704$500kunder 0.1%Newnew12 Aug 2026 (the filing on sec.gov)
Susquehanna International Group LLP14,144$359kunder 0.1%Trimmed-21,33914 Aug 2026 (the filing on sec.gov)
Janus Henderson Group Ltd12,119$308kunder 0.1%Trimmed-11,20014 Aug 2026 (the filing on sec.gov)
Verition Fund Management LLC11,692$297kunder 0.1%Trimmed-18,22714 Aug 2026 (the filing on sec.gov)
Squarepoint Ops LLC10,566$268kunder 0.1%Trimmed-22,11914 Aug 2026 (the filing on sec.gov)
Neuberger Berman Group LLC10,405$264kunder 0.1%Newnew27 Oct 2026 (the filing on sec.gov)
Freestone Grove Partners LP5$00.00%Trimmed-36,41714 Aug 2026 (the filing on sec.gov)

Largest increases and reductions, by shares

Q1 2026 to Q2 2026, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (6)

Exited (4)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
4 in Q3 2024 to 3 in Q2 2026

Tracked managers listing it, at least.

0358102014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
PCRX by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20133$232mn.a.n.a.
Q3 20133$325mn.a.n.a.
Q4 20132$349mn.a.n.a.
Q1 20143$399mn.a.n.a.
Q2 20143$525mn.a.n.a.
Q3 20148$891mn.a.n.a.
Q4 20146$510mn.a.n.a.
Q1 20153$396mn.a.n.a.
Q2 20154$357mn.a.n.a.
Q3 20157$180mn.a.n.a.
Q4 20155$659mn.a.n.a.
Q1 20165$344mn.a.n.a.
Q2 20166$194mn.a.n.a.
Q3 20164$62mn.a.n.a.
Q4 20162$41mn.a.n.a.
Q1 20173$33mn.a.n.a.
Q2 20175$71mn.a.n.a.
Q3 20172$53mn.a.n.a.
Q4 20175$64mn.a.n.a.
Q1 20186$37mn.a.n.a.
Q2 20183$23mn.a.n.a.
Q3 20187$133mn.a.n.a.
Q4 20189$143mn.a.n.a.
Q1 20198$152mn.a.n.a.
Q2 20199$234mn.a.n.a.
Q3 201910$130mn.a.n.a.
Q4 20197$228mn.a.n.a.
Q1 20209$190mn.a.n.a.
Q2 20208$307mn.a.n.a.
Q3 20205$344mn.a.n.a.
Q4 20205$335mn.a.n.a.
Q1 20214$313mn.a.n.a.
Q2 20216$303mn.a.n.a.
Q3 20216$251mn.a.n.a.
Q4 20216$269mn.a.n.a.
Q1 20226$332mn.a.n.a.
Q2 20225$239mn.a.n.a.
Q3 20225$206mn.a.n.a.
Q4 20225$144mn.a.n.a.
Q1 20236$174mn.a.n.a.
Q2 20238$174mn.a.n.a.
Q3 20235$111mn.a.n.a.
Q4 20235$102m32
Q1 20243$108m22
Q2 20244$113m31
Q3 20244$41m32
Q4 20244$68m32
Q1 20257$178m61
Q2 20255$117m32
Q3 20254$109m04
Q4 20255$57m1711
Q1 20263$45m620
Q2 20263$49m1413

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

PCRX and LLY →PCRX and JNJ →PCRX and VRTX →Choose a stock to compare with PCRX →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own PCRX, latest filings →Back to the 13F Explorer →